InsiderClue
Insiders · Profile

Albers Jeffrey W.

Director at Spyre Therapeutics · Director at Kymera Therapeutics. Filing since 23 Jan 2024. CIK 0001638474

SYRE Spyre Therapeutics, Inc. Director · 4 trades KYMR Kymera Therapeutics, Inc. Director · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SYRE Spyre Therapeutics, Inc.
7 Aug 2026
Director
Sold on a plan
18,000
$1.88M
65.8%
SYRE Spyre Therapeutics, Inc.
7 Aug 2026
Director
Sold on a plan
5,000
$522.35K
100%
KYMR Kymera Therapeutics, Inc.
8 Dec 2025
Director
Sold on a plan
5,000
$448.82K
100%
KYMR Kymera Therapeutics, Inc.
13 Oct 2025
Director
Sold on a plan
5,000
$295.95K
100%
KYMR Kymera Therapeutics, Inc.
3 Jun 2025
Director
Sold on a plan
6,349
$311.10K
100%
SYRE Spyre Therapeutics, Inc.
6 Nov 2024
Director
Sold on a plan
6,700
$246.31K
19.7%
SYRE Spyre Therapeutics, Inc.
25 Oct 2024
Director
Sold on a plan
300
$10.93K
0.9%
KYMR Kymera Therapeutics, Inc.
26 Aug 2024
Director
Sold on a plan
5,000
$245.51K
100%
KYMR Kymera Therapeutics, Inc.
21 Feb 2024
Director
Sold on a plan
4,385
$171.23K
100%
KYMR Kymera Therapeutics, Inc.
20 Feb 2024
Director
Sold on a plan
615
$24.03K
100%
KYMR Kymera Therapeutics, Inc.
23 Jan 2024
Director
Sold on a plan
10,000
$300.47K
100%
11 decisions on file.